A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer
Academic Article
Publication Date:
2007
Iris type:
1.1 Articolo in rivista
List of contributors:
Geulibter, A. J.; Gamucci, T.; Pollera, C. F.; Di Costanzo, F.; Nuzzo, C.; Gabriele, A.; Signorelli, C.; Gasperoni, S.; Ferraresi, V.; Giannarelli, D.; Cognetti, F.; Zeuli, M.
Published in: